Suppr超能文献

采用艾沙康唑治疗上肢荚膜组织胞浆菌病。

Upper extremity Histoplasma capsulatum treatment with isavuconazole.

作者信息

Le Janet, Perkins David R, Sierra-Hoffman Miguel, Stevens Mark L, Binz Daniel, Saddler Kimberly, Castro-Lainez Miriams T, Deliz Rafael J

机构信息

Texas A&M Detar Family Residency Program, Victoria, TX, 77901, USA.

Texas A&M affiliated Detar Family Medicine Program, Victoria, TX, 77901, USA.

出版信息

IDCases. 2021 Aug 2;25:e01243. doi: 10.1016/j.idcr.2021.e01243. eCollection 2021.

Abstract

Extrapulmonary infections in the immunocompetent population are rare and pose a diagnostic challenge. Upper extremity histoplasmosis without a primary lung infection is uncommon. It is possible to acquire it by inadvertent trauma with direct inoculation. Our case describes an immunocompetent patient with progressive swelling with minimal pain in the wrist associated with a small puncture wound on the left dorsal forearm. The initial workup failed to identify a specific etiology. For the following six weeks, the patient experienced progressive worsening of symptoms, warranting a referral to an orthopedic hand surgeon. Left lower extremity magnetic resonance imaging (MRI) findings were non-specific. The surgeon performed a surgical exploration and debridement with the excision of hypertrophic tissue. Initial stains showed a granulomatous tissue but did not reveal an organism; however, a month later, mold was identified on the growth medium. The patient was initiated in isavuconazole empiric therapy. Four weeks later, a matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the diagnosis as . The patient had clinical remission with isavuconazole used as the United States Food and Drug Administration (FDA) off label use.

摘要

免疫功能正常人群的肺外感染较为罕见,且诊断具有挑战性。无原发性肺部感染的上肢组织胞浆菌病并不常见。可通过直接接种的意外创伤感染。我们的病例描述了一名免疫功能正常的患者,其手腕逐渐肿胀,疼痛轻微,左前臂背侧有一个小刺伤。初步检查未能确定具体病因。在接下来的六周里,患者症状逐渐恶化,因此转诊至手外科矫形医生处。左下肢磁共振成像(MRI)结果无特异性。外科医生进行了手术探查和清创,并切除了增生组织。初步染色显示为肉芽肿组织,但未发现病原体;然而,一个月后,在生长培养基上发现了霉菌。患者开始接受伊曲康唑经验性治疗。四周后,基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)确诊为 。患者使用伊曲康唑作为美国食品药品监督管理局(FDA)未批准的用药后临床症状缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f21f/8353508/50e6361340b2/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验